Impact of Prior Treatment on the Efficacy of Tabelecleucel for Epstein–Barr Virus-Driven Posttransplant Lymphoproliferative Disease: Subgroup Analysis from the phase 3 Allele Study

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Amer Beitinjaneh, Sarah Nikiforow, Kris Michael Mahadeo, Sridhar Chaganti, Sylvain Choquet, Daan Derickx, Armin Ghobadi, Roberta Valenti, Anke Friedetzky, Sandrine Roye, Ran Reshef, Susan E. Prockop
+1 more Robert A. Baiocchi
DOI: 10.1016/j.jtct.2025.12.207
Cited by: 0

Fields of Study & Subjects

Viral-associated cancers and disorders CAR-T cell therapy research Cytomegalovirus and herpesvirus research

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S151–S152
Publication date
1 February 2026
Language
EN